Atrium Therapeutics, Inc.
← Back to RNA Overview

Atrium Therapeutics, Inc. (RNA)

Solvency & Capital Structure

Total Debt

$2.7M

Net Debt

-$265.2M

Atrium Therapeutics, Inc. currently has $2.7M in total debt. Net debt is -$265.2M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

RNAQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.000.27-0.27Net Cash0.290.9%
2025-12-310.000.27-0.27Net Cash0.281.3%
2025-09-300.000.27-0.27Net Cash0.281.5%